3Xu ZG,lwatsuki K,Ohtsuka M. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders:a possible relation to the endemic occurrence of these disease in Japan[J].Journal of Medical Virology,2000,(02):239-246.doi:10.1002/1096-9071(200010)62:2<239::AID-JMV16>3.0.CO;2-Z.
4Xu ZG,Iwatuski K,Oyama K. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas[J].British Journal of Cancer,2001,(07):920-925.
5Miyashita E,Yang B,Babcock G. Identification of the site of Epstein-Barr virus latency in vivo as a resting B cell[J].Journal of Virology,1997,(07):4882-4891.
6Cohen JI,Kimura H,Nakamura S. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts:a status report and summary of an international meeting,8-9 September 2008[J].Annals of Oncology,2009,(09):1472-1482.
7Suzuki K,Ohshima K,Karube K. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults[J].International Journal of Oncology,2004,(05):1165-1174.
8Kimura H,Hoshino Y,Kanegane H. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection[J].Blood,2001,(02):280-286.doi:10.1182/blood.V98.2.280.
9Yim JH,Kim MY,Kim HO. Subcutaneous panniculitis-like T-cell lymphoma in a 26-month-old child with a review of the literature[J].Pediatric Dermatology,2006,(06):537-540.doi:10.1111/j.1525-1470.2006.00305.x.
10lwatsuki K,Xu Z,Takata M. The association of latent Epstein-Barr virus infection with hydroa vacciniforme[J].British Journal of Dermatology,1999,(04):715-721.
2Cho KH,Lee SH,Kim CW,et al.Epstein-Barr virus-associated lymphoproliferartive lesions presenting as a hydoa vacciniforme-like eruptioman analysis of six cases[J].Br J Dermatol,2004,151(2):372-380.
3Savoldo B,Huls MH,Liu Z,et al.Autologous Epstein-Barr virus(EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection[J].Blood,2002,100(12):4059-4066.
4Sato E,Ohga S,Kuroda H,et al.Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer- celllymphoproliferative disease in Japan[J].Am J Hematol,2008,83(9):721-727.
5Iwatsuki K,Satch M,Yamamoto T,et al.Pathogenic link between hydroa vacciniforme and Epstein-Barr virusp associated hematologic disorders[J].Arch Dermatol,2006,142(5):587-595.
